Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800120 · ClinicalTrials.gov registry record · NA
Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress
A NA study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04800120 is a NA study that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 6 participants.
The verdict
NCT04800120, a NA study, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Investigate whether hyperbaric oxygen therapy treatment can become a viable treatment option for COVID-19. If successful, providers will be able to provide future COVID-19 patients with mild-to-moderate respiratory distress hyperbaric oxygen therapy in order to help avoid mechanical ventilation
Interventions
- OTHER Hyperbaric Oxygen Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04800120
The ClinicalTrials.gov registry entry for NCT04800120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT04800120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04800120 about?
NCT04800120 is a clinical study titled "Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress". Investigate whether hyperbaric oxygen therapy treatment can become a viable treatment option for COVID-19. If successful, providers will be able to provide future COVID-19 patients with mild-to-moderate respiratory distress hyperbaric oxygen therapy in order to help avoid mechanical ventilation
What is the current status of trial NCT04800120?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-15. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT04800120?
The interventions under investigation include: Hyperbaric Oxygen Therapy (OTHER).
Who is sponsoring clinical trial NCT04800120?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.